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Background Myoclonus–dystonia syndrome (MDS) is a rare 
autosomal-dominant movement disorder characterized by brief, frequently 
alcohol-responsive myoclonic jerks that begin in childhood or early adolescence, caused 
by mutations in the SGCE gene. Case The patient was a 6-year-old boy. At 2 years and 
8 months, he presented with abnormal movement when he ran due to dystonia of his left 
leg. At 3 years and 5 moths, he exhibited dystonia and myoclonic movement of his arms 
when he ate something. His myoclonus was likely to develop when he felt anxiety or 
exhaustion. His genomic DNA showed a heterozygous mutation in the SGCE gene 
[c.109+1 G>T]. His father and uncle with the same mutation also experienced milder 
dystonia or myoclonic movements. Conclusion SGCE mutation can cause a broad 
clinical spectrum inter- and intra-families. We should consider MDS as a differential 
diagnosis for patients with paroxysmal walking abnormalities and/or myoclonic 
movements. 
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Syndromes presenting with dystonia can be divided into primary and secondary 
dystonia. Presently, 23 distinct monogenic primary dystonias (DYT1–25) have been 
recognized. DYT9 and DYT14 are now recognized as being identical to DYT18 and 
DYT5, respectively1, 2. Clinically, these dystonias are categorized into 3 groups: (1) 
pure dystonia, in which dystonia is occasionally accompanied by tremor, (2) dystonia 
plus syndromes, in which dystonia as the prominent sign co-occurs with other 
movement abnormalities, such as myoclonus and parkinsonism and (3) dyskinesia 
(paroxysmal dystonia), in which dystonia occurs as a paroxysmal sign in association 
with other movement anomalies and sometimes seizures3. Early-onset dystonia 
comprised many heterogeneous diseases and is sometimes difficult to diagnose in 
clinical practice.  
Myoclonus–dystonia syndrome (MDS; MIM #159900) is among dystonia plus 
syndromes, and a rare autosomal-dominant movement disorder characterized by brief, 
frequently alcohol-responsive myoclonic jerks that begin in childhood or early 
adolescence4. MDS is genetically heterogeneous because mutations in the ε-sarcoglycan 
  
(SGCE) gene on 7q21 are identified only in 30–40% patients5, and the SGCE gene is 
maternally imprinted, and only the paternal allele is expressed. This is the report on a 
Japanese familial case of MDS with a splicing mutation in SGCE. 
 
Case Report 
A 6-year-old boy (Figure 1, III-2) was born to nonconsanguineous parents at 39 
weeks and 3 days of gestational age, without asphyxia. At birth, his birth weight was 
3235 g (+0.6 SD), height was 47.6 cm (-0.7 SD), occipito-frontal circumference was 36 
cm (+1.9 SD). His motor development during infancy was slightly delayed: head 
control at 4 months, sitting alone at 6 months, standing and walking at 18 months. He 
started speaking complete words at 12 months. At 2 years and 8 months, the parents 
noticed that the boy’s left leg became extended when he ran. At 3 years and 5 moths, he 
exhibited abnormal movement of his right arm, but abnormal movement of his leg 
became unremarkable.  
The patient was referred to our medical center because of his abnormal 
involuntary movement at 3 years and 8 months of age. His weight and height were 12.7 
  
kg (−1.3 SD) and 84.4 cm (−3.7 SD), respectively. His neurological examination 
showed no particular neurological abnormalities including pyramidal or extrapyramidal 
signs, cerebellar ataxic signs, or asymmetric signs or symptoms.  
His routine blood analysis was normal. Electroencephalography showed no 
abnormal discharges. Brain magnetic resonance imaging showed no abnormal lesions. 
His electrophysiological tests, including motor conducting velocity and muscle 
electrography, were not available. 
His abnormal movements were as follows: when he tried to drink or eat 
something using his right hand, he could not control his arms, which either went too far 
to the left over his mouth or extended, and his head turned to the right or tilted to right, 
suggesting dystonia of the right arm and the left or right sternocleidomastoid, 
respectively. When he ate something with his left hand, his head turned to the right, 
suggesting dystonia of the left arm and left sternocleidomastoid. When he try to drink a 
cup of water with either his left or right hand, his arm sometimes exhibited fast 
movement, suggesting myoclonus, resulting in water spilling out of the cup. While 
running, his left leg seemed extended as though he was skipping. This occasionally 
  
resulted in a forward fall, suggesting dystonia of the left leg. He independently 
presented with dystonia and myoclonus. His abnormal movement did not show diurnal 
fluctuation. Dystonia of his lower extremities became unrecognizable as he grew up. 
His myoclonus is likely to develop when he feels anxiety or exhaustion, of while he eats 
or writing letters. No clonazepam nor carbamazepine seemed effective for his 
myoclonic or dystonic movement. At present, he appears healthy, and although he 
occasionally displays abnormal movements, they do not interfere with his daily life. 
His father (Figure 1, II-2) occasionally experienced stiffness in his hands during 
infancy, and sometimes has myoclonic movements of his arms when exhausted. His 
uncle (Figure 1, II-1) exhibited myoclonic movement of his arm during eating during 
his infancy and was diagnosed as having a tic. He also sometimes experienced 
myoclonic movements of his arms when exhausted. They did not consume alcohol and 
had no psychological problems.  
To identify the mutation causing this family’s autosomal-dominant dystonic 
syndrome, we performed whole-exome sequencing as described previously6. After 
written informed consent was provided, peripheral blood samples were obtained from 
  
the patient (Figure 1, III-2), his father (Figure 1, II-2) and mother (Figure 1, II-3), his 
brother (Figure 1, III-1), his uncle (Figure 1, II-1), his paternal grandfather (Figure 1, 
I-1), and his grandmother (Figure 1, I-2). We detected a heterozygous mutation 
consisting of a nucleotide change in the consensus sequence for the splice donor site in 
intron 1 in the SGCE gene [c.109+1 G>T] in three symptomatic family members, 
including the patient, his father, his uncle and his apparently asymptomatic grandfather 
(I-1). The mutation was not found in the asymptomatic family members, including his 
mother, brother and grandmother (I-2). This mutation is expected to be pathogenetic, 
because it has been already reported in a large family with MDS7, and the mutation was 
shown to cause an abnormal splicing. 
 
Discussion 
We identified on a known splicing mutation of SGCE in a family with MDS, and 
detailed clinical symptoms and neurological features of the proband were reported. Our 
case is characteristic in that he presented with an initial symptom of one-sided leg 
dystonia only while running at 2 years and 8 months old. In a recent study on nine MSD 
  
patients under 18 years old, SGCE mutations were identified in seven patients8. In most 
of these patients, dystonia simultaneously appeared with myoclonus, or later than 
myoclonus, with onset occurring from 8 months to 9 years in 8 out of 9 patients.  
The family described in this report showed the same splicing mutation with the 
patient reported previously, exhibiting a unique phenotype mimicking moyamoya 
disease7. None of the patient’s family members presented with moyamoya disease, 
suggesting that this splicing mutation is unlikely to be involved in the onset of 
moyamoya disease. Additionally, None of our families were heavy drinkers, and had 
any psychiatric disorders like those patients. It has been suggested that excess alcohol 
consumption in MDS could be a consequence of primary disorder of compulsive 
behavior, rather than the result of a therapeutic effect of alcohol on myoclonus9. Careful 
observation of the present family suggests that this SGCE mutation is not necessarily 
cause psychiatric features as reported previously, and that there is a broad clinical 
spectrum inter- and intra-families. 
The patient’s grandfather (Figure 1, I-1), who carried the mutation, showed no 
apparent signs and symptoms. This may be because his mutated allele was inherited 
  
from his mother and, since SGCE is maternally imprinted, the mutated maternal allele is 
not transcribed and the normal paternal allele is expressed, although this was not 
confirmed. This imperfect penetrance may make sometimes diagnosis difficult.  
In the previous report, trihexyphenidyl and clonazepam seemed more useful than 
carbamazepine, levetiracetam, valproate, or gabapentin. Deep brain stimulation of the 
globus pallidus pars interna seems effective in some adults and children with MDS. 
Spontaneous remission of dystonia and myoclonus may occur in approximately 20% 
and 5% patients with MDS during childhood or adolescence, respectively10. As 
observed in our patients, some patients can grow out of dystonia and myoclonus without 
any treatment, and we have to carefully consider the choice and timing of treatment11.  
We should consider MDS as a differential diagnosis for infants with paroxysmal 
abnormal movements of arms or legs.  
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Figure 1; A family tree of the present family and the eletcrophoregrams of the Sanger 
sequencing of SGCE. 
Details are described in the text.  
WT: wild allele 

